Clinical Trial Update: Statins and Risk of Myocardial Infarction in Real Life in France

View source ↗

Summary

A real-world observational update assessing whether statin use affects the risk of myocardial infarction in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Statins (class) (HMG-CoA reductase inhibitor)

Snippet

Sponsor: AstraZeneca | Conditions: Myocardial Infarction | Status: COMPLETED